AU6393498A - Polypeptide with appetite regulating activity - Google Patents

Polypeptide with appetite regulating activity

Info

Publication number
AU6393498A
AU6393498A AU63934/98A AU6393498A AU6393498A AU 6393498 A AU6393498 A AU 6393498A AU 63934/98 A AU63934/98 A AU 63934/98A AU 6393498 A AU6393498 A AU 6393498A AU 6393498 A AU6393498 A AU 6393498A
Authority
AU
Australia
Prior art keywords
polypeptide
regulating activity
appetite regulating
appetite
activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU63934/98A
Inventor
Kennet Christiansen
Sven Hastrup
Martin Edward Judge
Peter Kristensen
Lars Thim
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk AS
Original Assignee
Novo Nordisk AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk AS filed Critical Novo Nordisk AS
Publication of AU6393498A publication Critical patent/AU6393498A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475Growth factors; Growth regulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00Genetically modified animals
    • A01K2217/05Animals comprising random inserted nucleic acids (transgenic)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Child & Adolescent Psychology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU63934/98A 1997-03-26 1998-03-26 Polypeptide with appetite regulating activity Abandoned AU6393498A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DK35897 1997-03-26
DK358/97 1997-03-26
DK131597 1997-11-19
DK1315/97 1997-11-19
PCT/DK1998/000128 WO1998042747A1 (en) 1997-03-26 1998-03-26 Polypeptide with appetite regulating activity

Publications (1)

Publication Number Publication Date
AU6393498A true AU6393498A (en) 1998-10-20

Family

ID=26063851

Family Applications (1)

Application Number Title Priority Date Filing Date
AU63934/98A Abandoned AU6393498A (en) 1997-03-26 1998-03-26 Polypeptide with appetite regulating activity

Country Status (4)

Country Link
EP (1) EP0971957A1 (en)
JP (1) JP2002538757A (en)
AU (1) AU6393498A (en)
WO (1) WO1998042747A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6376657B1 (en) 1997-04-15 2002-04-23 Csir Pharmaceutical compositions having appetite suppressant activity
GB2355657B (en) 1999-10-27 2004-07-28 Phytopharm Plc Inhibitors Of Gastric Acid Secretion
GB2363985B (en) 2000-06-30 2004-09-29 Phytopharm Plc Extracts,compounds & pharmaceutical compositions having anti-diabetic activity and their use
WO2002008275A2 (en) * 2000-07-26 2002-01-31 Bayer Corporation Genes expressed in obese rat hypothalamus
RU2010114034A (en) * 2007-09-11 2011-10-20 Мондобайотек Лабораториз Аг (Li) THERAPEUTIC USE OF THE NEUROPEPTIDE EI AND ACTH 7-38 AND THEIR COMBINATIONS
AU2009226966A1 (en) * 2008-03-20 2009-09-24 Msd Oss B.V. Preparation of a pharmaceutical composition for increasing bone mineral density
CN112759634B (en) * 2021-01-21 2022-04-08 浙江辉肽生命健康科技有限公司 Bioactive peptide with amino acid structure FEYIEENKY, and preparation method and application thereof
CN112724239B (en) * 2021-01-22 2022-04-08 浙江辉肽生命健康科技有限公司 Bioactive peptide with amino acid structure NKELDPVQKLFVDKIREYK and application thereof
WO2023078478A1 (en) * 2021-11-08 2023-05-11 Ustav Organicke Chemie A Biochemie Av Cr, V. V. I. Lipidized cocaine- and amphetamine-regulated transcript peptide analogues as anti-obesity and neuroprotective agents

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996034619A1 (en) * 1995-05-04 1996-11-07 Amgen Inc. Methods of preventing neuron degeneration and promoting neuron regeneration

Also Published As

Publication number Publication date
WO1998042747A1 (en) 1998-10-01
EP0971957A1 (en) 2000-01-19
JP2002538757A (en) 2002-11-12

Similar Documents

Publication Publication Date Title
AU6241698A (en) Tace-like and matrilysin-like polypeptides
AU2639095A (en) Recombinant hk2 polypeptide
AU6208098A (en) Protein with phospholipase activity
AU6255096A (en) Pegylated modified proteins
AU8968198A (en) Wrist support
AUPP029497A0 (en) Wrist support
AU8016398A (en) Peptides with antiviral activity
AU9770498A (en) Regulator
EP1015474A4 (en) Don-1 gene and polypeptides and uses therefor
AU6393498A (en) Polypeptide with appetite regulating activity
AU8679098A (en) Outdoor deck material
AU4030697A (en) Proteins having telomerase activity
AU7727298A (en) Neuregulin response element and uses therefor
AU4930399A (en) Novel Polypeptide
AU1965497A (en) Cardiotrophin and uses therefor
AU6000698A (en) Proteins
AU6275098A (en) Novel h-rev 107-like protein
AU6421298A (en) Novel synthetic polypeptide
AU6160598A (en) Differentiation enhancing factors and uses therefor
AU6007098A (en) Bioreactor control
AU5724998A (en) Breathing regulator
AU1184800A (en) Novel polypeptide
AU8226598A (en) Plant genes and polypeptides and uses thereof
AU6148798A (en) Synthetic genes for recombinant mycobacterium proteins
AU9263398A (en) Analog trimming